search
Back to results

Biorhythms in Metabolic Tissues

Primary Purpose

Sleep Deprivation, Metabolic Disturbance, Biological Clocks

Status
Unknown status
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Low-fat dietary intervention
High-fat dietary intervention
Sponsored by
Uppsala University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Sleep Deprivation

Eligibility Criteria

18 Years - 32 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age 18-33 yr
  • Healthy (self-reported) and not on medication
  • BMI 18-28 kg/m2 (and waist circumference <102 cm), and weight stable (±5% body weight in past 6 months)
  • Non-smoker and non-nicotine user
  • Regular sleep-wake pattern, with sleep duration of 7-9.25 hrs per night
  • Sedentary to moderately active with regular exercise habits the last 2 months
  • Regular daily meal pattern with 3 main meals

Exclusion Criteria:

  • Major or chronic illness, e.g. diabetes, renal disease or inflammatory bowel disease
  • Current or history of endocrine or metabolic disorders
  • Psychiatric or neurological disorders (e.g. bipolar disorder, epilepsy)
  • Frequent gastrointestinal symptoms
  • Chronic medication
  • Any sleep disorder (e.g. irregular bedtimes, symptoms of insomnia)
  • Any issues with or allergies against the provided food items or utilized anesthesia
  • Shift work in the preceding three months or for a long duration
  • Time travel over two time zones in the preceding month
  • Too much weight gain or weight loss in the preceding 6 months
  • Pregnancy

Sites / Locations

  • Department of Neuroscience, Uppsala UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Healthy diet

Unhealthy diet

Arm Description

'Low-fat dietary intervention' to be administered to participants

'High-fat dietary intervention' to be administered to participants

Outcomes

Primary Outcome Measures

Changes in clock gene & associated omic circadian rhythms
Changes in clock gene & associated clock-regulated & clock-independent metabolic and omic circadian rhythms (e.g. in epigenome, transcriptome, metabolites) in peripheral tissues (primarily skeletal muscle and adipose tissue), and interplay between these rhythms across the 24-h period and under the different dietary conditions

Secondary Outcome Measures

Wakefulness-induced changes and subsequent recovery at omic levels
Changes at omic levels (e.g. DNA methylation, transcriptome, proteome, metabolome) in peripheral tissues (primarily skeletal muscle and adipose tissue), urine and feces samples due to extended wakefulness following subsequent recovery, following each dietary intervention
24-h rhythms in blood
Changes in rhythms in blood-borne cells, proteins and other molecular factors such as DNA, hormones, and proteins, due to the preceding dietary intervention, and relation to other rhythms measured across 24 hrs following the two dietary conditions
Diet-induced changes in gut microbiota and relation to circadian rhythms
Changes in gut microbiota (metagenomic, compositional) due to dietary intervention, and relation to circadian rhythms measured across 24 hrs in peripheral tissues following the two dietary conditions
Energy expenditure rhythms
Changes in energy expenditure rhythms due to the preceding dietary intervention, and relation to other rhythms measured across 24 hrs following the two dietary conditions
Urine metabolite rhythms
Changes in levels of urine metabolites due to dietary intervention, and relation to circadian rhythms across 24 hrs in peripheral tissues following the two dietary conditions
Rhythms of blood markers of damage to the central nervous system
Assessment of rhythms in of blood markers of damage to the central nervous system (e.g. Olink Proseek multiplex panel, neuron-specific enolase, S-100b) across a 24-h period and following subsequent recovery sleep, following the two dietary conditions
24-h rhythms in saliva
Changes in rhythms in saliva-borne cells, proteins and other molecular factors such as DNA, hormones, and proteins, due to the preceding dietary intervention, and relation to other rhythms measured across 24 hrs following the two dietary conditions
Central circadian rhythms
Changes in centrally driven circadian rhythms (e.g. temperature and melatonin), due to the preceding dietary intervention, and relation to other rhythms measured across 24 hrs following the two dietary conditions

Full Information

First Posted
August 28, 2017
Last Updated
October 10, 2017
Sponsor
Uppsala University
Collaborators
The Swedish Research Council
search

1. Study Identification

Unique Protocol Identification Number
NCT03276442
Brief Title
Biorhythms in Metabolic Tissues
Official Title
Biological Rhythms in Metabolic Tissues: Impact of Diet
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Unknown status
Study Start Date
August 31, 2017 (Actual)
Primary Completion Date
November 30, 2019 (Anticipated)
Study Completion Date
December 31, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Uppsala University
Collaborators
The Swedish Research Council

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Metabolism is increasingly recognized as being highly regulated by anticipatory biological rhythms (circadian rhythms or "biorhythms"), which are driven by molecular feedback loops, and which are approximately 24 hours long ("circa diem"). These circadian rhythms exist both centrally, in the brain, but also in the periphery, and are specific to many tissues depending on their main biological function or functions. Whereas these circadian rhythms have been thoroughly characterized in other organisms, their role in humans remain poorly understood, partly because of the difficulty in studying these rhythms in peripheral tissues. The investigators therefore aim to characterize these rhythms in primarily skeletal muscle and adipose tissue in healthy young volunteers (using the so-called constant routine paradigm), and how these rhythms interact with one another at various genetic and molecular levels. At the same time, the investigators aim to study how an unhealthy vs. healthy diet can alter these circadian rhythms, and how they interact with circadian rhythms in other tissue compartments such as those expressed by blood cells.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Deprivation, Metabolic Disturbance, Biological Clocks, Healthy

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Participants will be studied in a crossover design both after a "healthy diet", and after an "unhealthy diet"
Masking
None (Open Label)
Masking Description
In the crossover subgroup condition, participants will not be briefed about what diet they will receive before the actual onset of the dietary intervention
Allocation
Randomized
Enrollment
12 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Healthy diet
Arm Type
Experimental
Arm Description
'Low-fat dietary intervention' to be administered to participants
Arm Title
Unhealthy diet
Arm Type
Experimental
Arm Description
'High-fat dietary intervention' to be administered to participants
Intervention Type
Other
Intervention Name(s)
Low-fat dietary intervention
Intervention Description
Low-fat diet (5-7 days) preceding extended wakefulness under standardized conditions
Intervention Type
Other
Intervention Name(s)
High-fat dietary intervention
Intervention Description
High-fat diet (5-7 days) preceding extended wakefulness under standardized conditions
Primary Outcome Measure Information:
Title
Changes in clock gene & associated omic circadian rhythms
Description
Changes in clock gene & associated clock-regulated & clock-independent metabolic and omic circadian rhythms (e.g. in epigenome, transcriptome, metabolites) in peripheral tissues (primarily skeletal muscle and adipose tissue), and interplay between these rhythms across the 24-h period and under the different dietary conditions
Time Frame
Measured repeatedly (every 6 hours for 24 hours) during a period of extended wakefulness, following each dietary intervention (i.e. over a total period of 6-7 weeks)
Secondary Outcome Measure Information:
Title
Wakefulness-induced changes and subsequent recovery at omic levels
Description
Changes at omic levels (e.g. DNA methylation, transcriptome, proteome, metabolome) in peripheral tissues (primarily skeletal muscle and adipose tissue), urine and feces samples due to extended wakefulness following subsequent recovery, following each dietary intervention
Time Frame
Following each dietary intervention (i.e. over a total period of 6-7 weeks), measured repeatedly (every 2-6 hours for 24 hours) during a period of extended wakefulness, and after recovery sleep
Title
24-h rhythms in blood
Description
Changes in rhythms in blood-borne cells, proteins and other molecular factors such as DNA, hormones, and proteins, due to the preceding dietary intervention, and relation to other rhythms measured across 24 hrs following the two dietary conditions
Time Frame
Measured repeatedly (every 2-3 hours over 24 hours) during a period of extended wakefulness and after subsequent recovery, following each dietary intervention (i.e. over a total period of 6-7 weeks)
Title
Diet-induced changes in gut microbiota and relation to circadian rhythms
Description
Changes in gut microbiota (metagenomic, compositional) due to dietary intervention, and relation to circadian rhythms measured across 24 hrs in peripheral tissues following the two dietary conditions
Time Frame
Measured throughout study participation, i.e. on average over 6-7 weeks
Title
Energy expenditure rhythms
Description
Changes in energy expenditure rhythms due to the preceding dietary intervention, and relation to other rhythms measured across 24 hrs following the two dietary conditions
Time Frame
Measured repeatedly (every 2 hours over 24 hours) during a period of extended wakefulness and after subsequent recovery, following each dietary intervention (i.e. over a total period of 6-7 weeks)
Title
Urine metabolite rhythms
Description
Changes in levels of urine metabolites due to dietary intervention, and relation to circadian rhythms across 24 hrs in peripheral tissues following the two dietary conditions
Time Frame
Measured throughout study participation, i.e. on average over 6-7 weeks
Title
Rhythms of blood markers of damage to the central nervous system
Description
Assessment of rhythms in of blood markers of damage to the central nervous system (e.g. Olink Proseek multiplex panel, neuron-specific enolase, S-100b) across a 24-h period and following subsequent recovery sleep, following the two dietary conditions
Time Frame
Measured repeatedly (every 1-3 hours over 24 hours) during a period of extended wakefulness and after subsequent recovery, following each dietary intervention (i.e. over a total period of 6-7 weeks)
Title
24-h rhythms in saliva
Description
Changes in rhythms in saliva-borne cells, proteins and other molecular factors such as DNA, hormones, and proteins, due to the preceding dietary intervention, and relation to other rhythms measured across 24 hrs following the two dietary conditions
Time Frame
Measured repeatedly (every 2-3 hours over 24 hours) during a period of extended wakefulness and after subsequent recovery, following each dietary intervention (i.e. over a total period of 6-7 weeks)
Title
Central circadian rhythms
Description
Changes in centrally driven circadian rhythms (e.g. temperature and melatonin), due to the preceding dietary intervention, and relation to other rhythms measured across 24 hrs following the two dietary conditions
Time Frame
Measured repeatedly (every 1-3 hours over 24 hours) during a period of extended wakefulness and after subsequent recovery, following each dietary intervention (i.e. over a total period of 6-7 weeks)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
32 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 18-33 yr Healthy (self-reported) and not on medication BMI 18-28 kg/m2 (and waist circumference <102 cm), and weight stable (±5% body weight in past 6 months) Non-smoker and non-nicotine user Regular sleep-wake pattern, with sleep duration of 7-9.25 hrs per night Sedentary to moderately active with regular exercise habits the last 2 months Regular daily meal pattern with 3 main meals Exclusion Criteria: Major or chronic illness, e.g. diabetes, renal disease or inflammatory bowel disease Current or history of endocrine or metabolic disorders Psychiatric or neurological disorders (e.g. bipolar disorder, epilepsy) Frequent gastrointestinal symptoms Chronic medication Any sleep disorder (e.g. irregular bedtimes, symptoms of insomnia) Any issues with or allergies against the provided food items or utilized anesthesia Shift work in the preceding three months or for a long duration Time travel over two time zones in the preceding month Too much weight gain or weight loss in the preceding 6 months Pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jonathan Cedernaes, M.D., Ph.D.
Phone
0184714136
Email
jonathan.cedernaes@neuro.uu.se
First Name & Middle Initial & Last Name or Official Title & Degree
Christian Benedict, Ph.D.
Phone
0184714136
Email
christian.benedict@neuro.uu.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jonathan Cedernaes
Organizational Affiliation
Uppsala University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Neuroscience, Uppsala University
City
Uppsala
ZIP/Postal Code
75324
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jonathan Cedernaes, MD, PhD
Phone
+46184714102
Email
jonathan.cedernaes@neuro.uu.se
First Name & Middle Initial & Last Name & Degree
Christian Benedict, PhD
Phone
46184714136
Email
christian.benedict@neuro.uu.se
First Name & Middle Initial & Last Name & Degree
Jonathan Cedernaes, MD, PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Biorhythms in Metabolic Tissues

We'll reach out to this number within 24 hrs